1. Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients 
Stavros G. Drakos, MD, Abdallah G. Kfoury, MD, James W. Long, MD, James C. Stringham, MD, Thomas C. Fuller, PhD, Karl E. Nelson, RN, Beverly K. Campbell, RN, Edward M. Gilbert, MD, Dale G. Renlund, MD 
The Annals of Thoracic Surgery 
Volume 82, Issue 3, Pages (September 2006)
DOI: /j.athoracsur
Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Incidence of sensitization. (Gray bars = intravenous immunoglobulin; black bars = no intravenous immunoglobulin; LVAD = left ventricular assist device; NS = not significant.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Panel reactive antibody (PRA). (Gray bars = intravenous immunoglobulin; black bars = no intravenous immunoglobulin; LVAD = left ventricular assist device; NS = not significant.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Overall sensitization rates during left ventricular assist device support. (Gray bars = intravenous immunoglobulin; black bars = no intravenous immunoglobulin; PRA = panel reactive antibody.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

5. Fig 4
Peak panel reactive antibody (PRA). (Gray bar = intravenous immunoglobulin; black bar = no intravenous immunoglobulin.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions